1887

Journal of General Virology header logo

Volume 69, Issue 6

Prokaryotic Expression of Immunogenic Polypeptides of the Large Phosphoprotein (pp150) of Human Cytomegalovirus Free

Abstract

Summary

The large phosphorylated matrix protein pp150 of human cytomegalovirus (HCMV) is the polypeptide most frequently reactive in immunoblotting analyses with human antisera when compared with other viral proteins. Several defined regions of pp150 were expressed as β-galactosidase fusion proteins and these were tested for their immunoreactivity with human sera and their immunogenicity. One antigenic region could be expressed in large amounts and was found to carry immunodominant epitopes, as shown by immunoblotting and ELISA. A rabbit antiserum raised against recombinant pp150 antigens produced in bacteria proved to be useful for immunofluorescence and immunohistochemistry studies of HCMV-infected cells and tissues. The results suggest that this anti-pp150 serum will help to elucidate the process of virus assembly and antigen detection in infected cells.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): CMV , fusion protein , human and protein pp150
© Society for General Microbiology 1988
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-69-6-1195
1988-06-01
2024-04-25
Loading full text...

Full text loading...

/deliver/fulltext/jgv/69/6/JV0690061195.html?itemId=/content/journal/jgv/10.1099/0022-1317-69-6-1195&mimeType=html&fmt=ahah

References

  1. ARGOS P., HANEI M., GARAVITO M. 1978; The Chou-Fasman secondary structure prediction method with an extended data base. FEBS Letters 93:19–24
     [Google Scholar]
  2. AX W., KANZY E.-J., SEILER F. R. 1981; In-vivo phagocytosis: enhancement of bacterial clearance by native and enzyme-treated immunoglobulins. Immunobiology 159:349–365
     [Google Scholar]
  3. BALACHANDRAN N., OBA D. E., HUTT-FLETCHER L. M. 1987; Antigenic cross-reactions among herpes simplex virus type 1 and 2, Epstein-Barr virus and cytomegalovirus. Journal of Virology 61:1125–1135
     [Google Scholar]
  4. BORISCH B., JAHN G., SCHOLL B.-C, FILGER-BRILLINGER J., HEYMER B., FLECKENSTEIN B., MÜLLER-HERMELINK H. K. 1988; Detection of human cytomegalovirus DNA and viral antigens in tissues of different manifestations of CMV-infection. Virchows Archiv B: Celt Pathology including Molecular Pathology in press
    [Google Scholar]
  5. BROKER M. 1986; Vectors for regulated high-level expression of proteins fused to truncated forms of Escherichia coli β-galactosidase. Gene Analysis Techniques 3:53–57
     [Google Scholar]
  6. CHOU P. Y., FASMAN G. D. 1974; Prediction of protein conformation. Biochemistry 13:222–245
     [Google Scholar]
  7. CRANAGE M. P., KOUZARIDES T., BANKIER A. T., SATCHWELL S., WESTON K., TOMLINSON P., BARRELL B., HART H., BELL S. E., MINSON A. C., SMITH G. L. 1986; Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus. EMBO Journal 5:3057–3063
     [Google Scholar]
  8. DAVISON A. J., SCOTT J. E. 1986; DNA sequence of the major capsid protein gene of herpes simplex virus type 1. Journal of General Virology 67:2279–2286
     [Google Scholar]
  9. DEVEREUX J., HAEBERLI P., SMITHIES O. 1984; A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Research 12:387–395
     [Google Scholar]
  10. GIBSON W. 1983; Protein counterparts of human and simian cytomegalovirus. Virology 128:391–406
     [Google Scholar]
  11. HOPP T. P., WOODS K. R. 1981; Prediction of protein antigenic determinants from amino acid sequences. Proceedings of the National Academy of Sciences, U.S.A 78:3824–3828
     [Google Scholar]
  12. IRMIERE A., GIBSON W. 1983; Isolation and characterization of a noninfectious virion-like particle released from cells infected with human strains of cytomegalovirus. Virology 130:118–133
     [Google Scholar]
  13. JAHN G., SCHOLL B.-C., TRAUPE B., FLECKENSTEIN B. 1987a; The two major structural phosphoproteins (pp65 and pp150) of human cytomegalovirus and their antigenic properties. Journal of General Virology 68:1327–1337
     [Google Scholar]
  14. JAHN G., KOUZARIDES T., MACH M., SCHOLL B.-C, PLACHTER B., TRAUPE B., PREDDIE E., SATCHWELL S. C, FLECKENSTEIN B., BARRELL B. G. 1987b; Map position and nucleotide sequence of the gene for the large structural phosphoprotein of human cytomegalovirus. Journal of Virology 61:1358–1367
     [Google Scholar]
  15. KIM K. S., SAPIENZA V. J., CARP R. I., MOON H. M. 1976; Analysis of structural polypeptides of purified human cytomegalovirus. Journal of Virology 20:604–611
     [Google Scholar]
  16. KOUZARIDES T., BANKIER A. T., SATCHWELL S. C, WESTON K., TOMLINSON P., BARRELL B. G. 1987; Large-scale rearrangement of homologous regions in the genomes of HCMV and EBV. Virology 157:397–413
     [Google Scholar]
  17. LAEMMLI U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, London 227:680–685
     [Google Scholar]
  18. LANDINI M. P., RE M. C, MIROLO G., BALDASSARRI B., LA PLACA M. 1985; Human immune response to cytomegalovirus structural polypeptides studied by immunoblotting. Journal of Medical Virology 17:303–311
     [Google Scholar]
  19. LANDINI M. P., MIROLO G., COPPOLECCHIA P., RE M. C, LA PLACA M. 1986; Serum antibodies to individual cytomegalovirus structural polypeptides in renal transplant recipients during viral infection. Microbiology and Immunology 30:683–695
     [Google Scholar]
  20. MACH M., UTZ U., FLECKENSTEIN B. 1986; Mapping of the major glycoprotein gene of human cytomegalovirus. Journal of General Virology 67:1461–1467
     [Google Scholar]
  21. MACKOWIAK P. A., MARLING-CASON M. 1987; Immunoreactivity of cytomegalovirus-induced Fc receptors. Microbiology and Immunology 31:427–434
     [Google Scholar]
  22. MESSING J., GRONENBORN B., MÜLLER-HILL B., HOFSCHNEIDER P. H. 1977; Filamentous coliphage M13 as a cloning vehicle: insertion of a HinàlW fragment of the lac regulatory region in M13 replicative form in vitro. Proceedings of the National Academy of Sciences, U.S.A 74:3642–3646
     [Google Scholar]
  23. NOWAK B., GMEINER A., SARNOW P., LEVINE A. I., FLECKENSTEIN B. 1984a; Physical mapping of human cytomegalovirus genes: identification of DNA sequences coding for a virion phosphoprotein of 71-kDA and a viral 65-kDa polypeptide. Virology 134:91–102
     [Google Scholar]
  24. NOWAK B., SULLIVAN C, SARNOW P., THOMAS R., BRICOUT F., NICOLAS J. C, FLECKENSTEIN B., LEVINE A. J. 1984b; Characterization of monoclonal antibodies and polyclonal immune sera directed against human cytomegalovirus virion proteins. Virology 132:325–338
     [Google Scholar]
  25. PANDE H., BAAK S. W., RIGGS A. D., CLARK B. R., SHIVELY I. E., ZAIA J. A. 1984; Cloning and physical mapping of a gene fragment coding for a 64-kilodalton major late antigen of human cytomegalovirus. Proceedings of the National Academy of Sciences, U.S.A 81:4965–4969
     [Google Scholar]
  26. PEREIRA L., HOFFMAN M., CREMER N. 1982; Electrophoretic analysis of polypeptides immune-precipitated from cytomegalovirus-infected cell extracts by human sera. Infection and Immunity 36:933–942
     [Google Scholar]
  27. PEREIRA L., STAGNO S., HOFFMAN M., VOLANAKIS J. E. 1983; Cytomegalovirus-infected cell polypeptides immune-precipitated by sera from children with congenital and perinatal infections. Infection and Immunity 39:100–108
     [Google Scholar]
  28. RÜGER B., KLAGES S., WALLA B., ALBRECHT I., FLECKENSTEIN B., TOMLINSON P., BARRELL B. 1987; Primary structure and transcription of the genes coding for the two virion phosphoproteins pp65 and pp71 of human cytomegalovirus. Journal of Virology 61:446–453
     [Google Scholar]
  29. SANGER F., NICKLEN S., COULSON A. R. 1977; DNA sequencing with chain-terminating inhibitors. Proceedings of the National Academy of Sciences, U.S.A 74:5463–5467
     [Google Scholar]
  30. SCHMITZ H., MÜLLER-LANTZSCH N., PETELER G. 1980; Human immune response to proteins of cytomegalovirus. Intervirology 13:154–161
     [Google Scholar]
  31. SNOWDEN W., HALLIBURTON I. W. 1985; Identification of cross-reacting glycoproteins of four herpesviruses by Western blotting. Journal of General Virology 66:2039–2044
     [Google Scholar]
  32. STINSKI M. F. 1976; Human cytomegalovirus: glycoproteins associated with virions and dense bodies. Journal of Virology 19:594–609
     [Google Scholar]
  33. TALBOT P., ALMEIDA J. D. 1977; Human cytomegalovirus: purification of enveloped virions and dense bodies. Journal of General Virology 36:345–349
     [Google Scholar]
  34. TOWBIN H., STAEHELIN T., GORDON J. 1979; Electrophoretic transfer of proteins from Polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proceedings of the National Academy of Sciences, U.S.A 76:4350–4354
     [Google Scholar]
  35. WOLF H., MODROW S., MOTZ M., JAMESON B., HERMANN G., FÖRTSCH B. 1988; An integrated family of amino acid sequence analysis programs. Computer Applications in the Biosciences 4:187–191
     [Google Scholar]
  36. YANISCH-PERRON C, VIEIRA J., MESSING J. 1985; Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mpl8 and pUC19 vectors. Gene 33:103–119
     [Google Scholar]
  37. YOUNG R. A., DAVIS R. W. 1983; Efficient isolation of genes by using antibody probes. Proceedings of the National Academy of Sciences, U.S.A 80:1194–1198
     [Google Scholar]
  38. ZAIA A., FORMAN J., TING Y-P., URBINA E., BLUME G. 1986; Polypeptide-specific antibody response to human cytomegalovirus after infection in bone marrow transplant recipients. Journal of Infectious Diseases 153:780–787
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-69-6-1195
Loading
Prokaryotic Expression of Immunogenic Polypeptides of the Large Phosphoprotein (pp150) of Human Cytomegalovirus
J. Gen. Virol. 69, 1195 (1988); https://doi.org/10.1099/0022-1317-69-6-1195
/content/journal/jgv/10.1099/0022-1317-69-6-1195
/content/journal/jgv/10.1099/0022-1317-69-6-1195
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error